Does VALGANCICLOVIR Cause Malignant neoplasm progression? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Malignant neoplasm progression have been filed in association with VALGANCICLOVIR (VALGANCICLOVIR). This represents 0.2% of all adverse event reports for VALGANCICLOVIR.
18
Reports of Malignant neoplasm progression with VALGANCICLOVIR
0.2%
of all VALGANCICLOVIR reports
8
Deaths
3
Hospitalizations
How Dangerous Is Malignant neoplasm progression From VALGANCICLOVIR?
Of the 18 reports, 8 (44.4%) resulted in death, 3 (16.7%) required hospitalization, and 10 (55.6%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALGANCICLOVIR. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does VALGANCICLOVIR Cause?
Off label use (1,882)
Cytomegalovirus infection (1,091)
Drug ineffective (886)
Neutropenia (809)
Leukopenia (574)
Drug resistance (524)
Cytomegalovirus viraemia (447)
Pancytopenia (434)
Cytomegalovirus infection reactivation (374)
Death (359)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which VALGANCICLOVIR Alternatives Have Lower Malignant neoplasm progression Risk?
VALGANCICLOVIR vs VALIUM
VALGANCICLOVIR vs VALPROATE
VALGANCICLOVIR vs VALPROIC ACID
VALGANCICLOVIR vs VALPROMIDE
VALGANCICLOVIR vs VALSARTAN